Stocks and Investing Stocks and Investing
Tue, October 17, 2023
Mon, October 16, 2023

David Westenberg Maintained (AKYA) at Buy with Decreased Target to $11 on, Oct 16th, 2023


Published on 2024-10-28 06:54:18 - WOPRAI, David Westenberg
  Print publication without navigation


David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $14 to $11 on, Oct 16th, 2023.

David has made no other calls on AKYA in the last 4 months.



There are 3 other peers that have a rating on AKYA. Out of the 3 peers that are also analyzing AKYA, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • John Sourbeer of "UBS" Maintained at Strong Buy with Decreased Target to $7 on, Thursday, October 12th, 2023
  • Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $16 on, Tuesday, August 8th, 2023
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $15 on, Tuesday, August 8th, 2023

Contributing Sources